The BIO International Convention is widely recognized as the world’s largest biotechnology event — a gathering of thousands...
Precision oncology in gastrointestinal malignancies is advancing rapidly — driven by an expanding landscape of clinically actionable biomarkers,...
Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science research tools, analytical instruments, and diagnostics, has announced...
Prostate cancer is not a single disease. Even within a single patient, multiple tumor foci can coexist in...
Among all the capabilities that cancer cells acquire during malignant progression, the ability to invade surrounding tissue and...
The study of complex tissues — whether in the context of brain development, tumor progression, or organ-level disease...
Understanding cancer at the tissue level requires more than knowing which genes are expressed — it requires knowing...
The identification of lead antibody candidates is one of the most resource-intensive phases of biotherapeutic development. As AI-enabled...
The gap between experimental design and laboratory execution has long been one of the more persistent inefficiencies in...
Science advances through data, discovery, and determination — but it moves the world through stories. At the 2026...